Amarin Corp Plc (AMRN)

[Keyser]

In my opinion, the issue before the Federal Circuit is less likely to be controlled by the political bent of the Justices on the panel than many cases. This case is far less a war on generics vs. bug pharma than it is doing the right thing under existing precedent. Du got both procedural and substantive issues wrong, including illogical and incorrect bases upon which she based her finding of obviousness.

I feel very good about our arguments and the way Singer and Fish &Richardson briefed them.

Don't get m wrong--I still would wish to have at least 2 pro-patent Justices on the panel, but this appeal is one that any remotely competent Fed. Cir. justice should reverse based on the law, medicine and raw logic.